Data on Antiretrovirals Discussed by a Researcher at Public Assistance - Paris Hospitals (AP-HP) (Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results)

MLA

“Data on Antiretrovirals Discussed by a Researcher at Public Assistance - Paris Hospitals (AP-HP) (Real-World Data on Long-Acting Intramuscular Maintenance Therapy with Cabotegravir and Rilpivirine Mirror Phase 3 Results).” Obesity, Fitness & Wellness Week, Oct. 2024, p. 83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.810477110&authtype=sso&custid=ns315887.

APA

Data on Antiretrovirals Discussed by a Researcher at Public Assistance - Paris Hospitals (AP-HP) (Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results). (2024, October 5). Obesity, Fitness & Wellness Week, 83.

Chicago

Obesity, Fitness & Wellness Week. 2024. “Data on Antiretrovirals Discussed by a Researcher at Public Assistance - Paris Hospitals (AP-HP) (Real-World Data on Long-Acting Intramuscular Maintenance Therapy with Cabotegravir and Rilpivirine Mirror Phase 3 Results),” October 5. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.810477110&authtype=sso&custid=ns315887.